MRNS

Marinus Pharmaceuticals, Inc
MRNS

Overview Fund Activity
Delisted

MRNS was delisted on the 10th of February, 2025.

Back to rankings

86 hedge funds and large institutions have $284M invested in Marinus Pharmaceuticals, Inc in 2023 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 31 increasing their positions, 22 reducing their positions, and 14 closing their positions.

Holders
86
Holders Change
+12
Holders Change %
+16.22%
% of All Funds
1.38%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
26
Increased
31
Reduced
22
Closed
14
Calls
$8.87M
Puts
$994K
Net Calls
+$7.88M
Net Calls Change
+$3.64M

Top Buyers

1
ACM
1
AIGH Capital Management
Maryland
$9.22M
2
SI
2
Sofinnova Investments
California
$8.28M
3
GC
3
GMT Capital
Georgia
$8.15M
4
Barclays
4
Barclays
United Kingdom
$4.44M
5
Franklin Resources
5
Franklin Resources
California
$7.08M

Top Sellers

1
LPC
1
Lion Point Capital
New York
$18.1M
2
VA
2
VR Adviser
New York
$0
3
AC
3
Antara Capital
New York
$0
4
Walleye Capital
4
Walleye Capital
New York
$213K
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$21.8M
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
101
Concourse Financial Group Securities
Alabama
– – – –
Belvedere Trading
102
Belvedere Trading
Illinois
– – – –
1 2 3 4
5